NDC properties for "Epogen" (RxCUI 205917)
About this data
The tables show NDC propoerties for Epogen with the RxCUI 205917
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Epogen (RxCUI 205917)
| BLA | BLA103234 |
|---|---|
| MMSL_CODE | BD30445 |
| RxCUI | 205917 |
| SPL_SET_ID | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
| Prescribable Synonym | EPOGEN 2000 UNT in 1 ML Injection |
| RXNAV_STR | 1 ML Epogen 2000 UNT/ML Injection |
| RxNorm Name | 1 ML epoetin alfa 2000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | 1 ML EPO 2000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | 1 ML Epogen 2000 UNT/ML Injection |
| RxNorm Synonym | 1 ML ERYTHROPOIETIN 2000 UNT/ML Injection [Epogen] |
| RxNorm Synonym | Epogen 2000 UNT per 1 ML Injection |
| Related queries | Interactions (for RxCUI 205917) |
NDC Properties
NDC Item 55513012601
| NDC 9 | 55513-126 |
|---|---|
| NDC 10 | 55513-126-01 |
| NDC Item | 55513012601 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1989-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-126 |
NDC Item 55513012610
| NDC 9 | 55513-126 |
|---|---|
| NDC 10 | 55513-126-10 |
| NDC Item | 55513012610 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-126-10) / 1 mL in 1 VIAL (55513-126-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1989-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-126 |
NDC Item 55513012601
| NDC 9 | 55513-126 |
|---|---|
| NDC 10 | 55513-126-01 |
| NDC Item | 55513012601 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1989-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-126 |
NDC Item 55513012610
| NDC 9 | 55513-126 |
|---|---|
| NDC 10 | 55513-126-10 |
| NDC Item | 55513012610 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-126-10) / 1 mL in 1 VIAL (55513-126-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1989-06-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-126 |